4//SEC Filing
Smith Devin Whittemore 4
Accession 0001567619-23-000919
CIK 0001865494other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 4:49 PM ET
Size
5.6 KB
Accession
0001567619-23-000919
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Smith Devin Whittemore
General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2023-01-12+150,000→ 150,000 totalExercise: $2.60Exp: 2033-01-12→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]One-fourth of these options vest on January 12, 2024, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the Issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control.
Documents
Issuer
IO Biotech, Inc.
CIK 0001865494
Entity typeother
Related Parties
1- filerCIK 0001747818
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 4:49 PM ET
- Size
- 5.6 KB